Literature DB >> 19713224

Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages.

Alexandra Briquet1, Sophie Dubois, Sandrine Bekaert, Marie Dolhet, Yves Beguin, André Gothot.   

Abstract

BACKGROUND: Bone marrow mesenchymal stem cells support proliferation and differentiation of hematopoietic progenitor cells in vitro. Since these cells constitute a rare subset of bone marrow cells, mesenchymal stem cell preparations for clinical purposes require a preparative step of ex vivo multiplication. The aim of our study was to analyze the influence of culture duration on mesenchymal stem cell supportive activity. DESIGN AND METHODS: Mesenchymal stem cells were expanded for up to ten passages. These cells and CD34+ cells were seeded in cytokine-free co-cultures after which the phenotype, clonogenic capacity and in vivo repopulating activity of harvested hematopoietic cells were assessed.
RESULTS: Early passage mesenchymal stem cells supported hematopoietic progenitor cell expansion and differentiation toward both B lymphoid and myeloid lineages. Late passage mesenchymal stem cells did not support hematopoietic progenitor cell and myeloid cell outgrowth but maintained B-cell supportive ability. In vitro maintenance of NOD/SCID mouse repopulating cells cultured for 1 week in contact with mesenchymal stem cells was effective until the fourth passage of the mesenchymal cells and declined thereafter. The levels of engraftment of CD34(+) cells in NOD/SCID mice was higher when these cells were co-injected with early passage mesenchymal stem cells; however mesenchymal cells expanded beyond nine passages were ineffective in promoting CD34(+) cell engraftment. Non-contact cultures indicated that mesenchymal stem cell supportive activity involved diffusible factors. Among these, interleukins 6 and 8 contributed to the supportive activity of early passage mesenchymal stem cells but not to those of late passage cells. The phenotype, as well as fat, bone and cartilage differentiation capacity, of mesenchymal stem cells did not change during their culture. Conclusions Extended culture of mesenchymal stem cells alters the ability of these cells to support hematopoietic progenitor cells without causing concomitant changes in their phenotype or differentiation capacity.

Entities:  

Mesh:

Year:  2009        PMID: 19713224      PMCID: PMC2805732          DOI: 10.3324/haematol.2009.008524

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  26 in total

1.  SSEA-4 identifies mesenchymal stem cells from bone marrow.

Authors:  Eun J Gang; Darko Bosnakovski; Camila A Figueiredo; Jan W Visser; Rita C R Perlingeiro
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

2.  Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction.

Authors:  Wolfgang Wagner; Frederik Wein; Christoph Roderburg; Rainer Saffrich; Anne Faber; Ulf Krause; Mario Schubert; Vladimir Benes; Volker Eckstein; Holger Maul; Anthony D Ho
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

3.  Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.

Authors:  X M Fei; Y J Wu; Z Chang; K R Miao; Y H Tang; X Y Zhou; L X Wang; Q Q Pan; C Y Wang
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

Review 4.  The interleukin-8 pathway in cancer.

Authors:  David J J Waugh; Catherine Wilson
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

5.  Regulation of human B lymphopoiesis by the transforming growth factor-beta superfamily in a newly established coculture system using human mesenchymal stem cells as a supportive microenvironment.

Authors:  Michiko Ichii; Kenji Oritani; Takafumi Yokota; Makoto Nishida; Isao Takahashi; Takahiro Shirogane; Sachiko Ezoe; Norimitsu Saitoh; Rie Tanigawa; Paul W Kincade; Yuzuru Kanakura
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

6.  Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.

Authors:  Guo-Ping Huang; Zhi-Jun Pan; Bing-Bing Jia; Qiang Zheng; Chun-Gang Xie; Jiang-Hong Gu; Ian K McNiece; Jin-Fu Wang
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

7.  Long-term in vitro expansion alters the biology of adult mesenchymal stem cells.

Authors:  Reza Izadpanah; Deepak Kaushal; Christopher Kriedt; Fern Tsien; Bindiya Patel; Jason Dufour; Bruce A Bunnell
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

8.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

9.  Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.

Authors:  Charalampia Kyriakou; Neil Rabin; Arnold Pizzey; Amit Nathwani; Kwee Yong
Journal:  Haematologica       Date:  2008-08-25       Impact factor: 9.941

10.  Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice.

Authors:  Mingxia Shi; Jing Li; Lianming Liao; Bin Chen; Bingzong Li; Lei Chen; Hairong Jia; Robert Chunhua Zhao
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

View more
  27 in total

1.  Mesenchymal stem cells secreting angiopoietin-like-5 support efficient expansion of human hematopoietic stem cells without compromising their repopulating potential.

Authors:  Maroun Khoury; Adam Drake; Qingfeng Chen; Di Dong; Ilya Leskov; Maria F Fragoso; Yan Li; Bettina P Iliopoulou; William Hwang; Harvey F Lodish; Jianzhu Chen
Journal:  Stem Cells Dev       Date:  2011-01-31       Impact factor: 3.272

Review 2.  The origins of mesenchymal stromal cell heterogeneity.

Authors:  Meirav Pevsner-Fischer; Sarit Levin; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

3.  Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways.

Authors:  Daniel J Medina; Lauri Goodell; John Glod; Céline Gélinas; Arnold B Rabson; Roger K Strair
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

4.  Effects of autologous stromal cells and cytokines on differentiation of equine bone marrow-derived progenitor cells.

Authors:  Ute E Schwab; Rebecca L Tallmadge; Mary Beth Matychak; M Julia B Felippe
Journal:  Am J Vet Res       Date:  2017-10       Impact factor: 1.156

5.  Aldehyde Dehydrogenase Activity in Adipose Tissue: Isolation and Gene Expression Profile of Distinct Sub-population of Mesenchymal Stromal Cells.

Authors:  Mehdi Najar; Emerence Crompot; Leo A van Grunsven; Laurent Dollé; Laurence Lagneaux
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

Review 6.  Mesenchymal stromal cells: a new tool against graft-versus-host disease?

Authors:  Frédéric Baron; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

7.  iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.

Authors:  Pan-Pan Cheng; Xiao-Cun Liu; Peng-Fei Ma; Chang Gao; Jia-Li Li; Ying-Ying Lin; Wei Shao; Shuo Han; Bin Zhao; Lu-Min Wang; Jia-Zhao Fu; Lu-Xi Meng; Qing Li; Qi-Zhou Lian; Jun-Jie Xia; Zhong-Quan Qi
Journal:  Stem Cells Dev       Date:  2015-05-18       Impact factor: 3.272

8.  Activation of CD74 inhibits migration of human mesenchymal stem cells.

Authors:  Bonnie L Barrilleaux; Benjamin W Fischer-Valuck; Jennifer K Gilliam; Donald G Phinney; Kim C O'Connor
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-03       Impact factor: 2.416

9.  Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model.

Authors:  A Daisy Goodrich; Nicole M Varain; Christine M Jeanblanc; Donna M Colon; Jaehyup Kim; Esmail D Zanjani; Peiman Hematti
Journal:  Cytotherapy       Date:  2014-09       Impact factor: 5.414

10.  Mesenchymal stem cells induce granulocytic differentiation of acute promyelocytic leukemic cells via IL-6 and MEK/ERK pathways.

Authors:  Fang Chen; Kang Zhou; Lei Zhang; Fengxia Ma; Dandan Chen; Junjie Cui; Xiaoming Feng; Shaoguang Yang; Ying Chi; Zhibo Han; Feng Xue; Lijuan Rong; Meili Ge; Li Wan; Shuxia Xu; Wenjing Du; Shihong Lu; Hongying Ren; Zhongchao Han
Journal:  Stem Cells Dev       Date:  2013-03-15       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.